|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
2/2021
vol. 123 abstract:
Guidelines/recommendations
Guidelines of the Polish Society of Ophthalmology for the treatment of exudative age-related macular degeneration
Marta Misiuk-Hojło
1
,
Iwona Grabska-Liberek
2
,
Katarzyna Michalska-Małecka
3
,
Ewa Mrukwa-Kominek
3
,
Bożena Romanowska-Dixon
4
,
Marcin Stopa
5
,
Jacek Szaflik
6
,
Jerzy Szaflik
6
,
Magdalena Ulińska
6
,
Joanna E. Adamiec-Mroczek
1
1.
Katedra i Klinika Okulistyki Uniwersytetu Medycznego we Wrocławiu
2.
Klinika Okulistyki CMKP w Warszawie
3.
Katedra i Klinika Okulistyki Śląskiego Uniwersytetu Medycznego
4.
Katedra i Klinika Collegium Medicum Uniwersytetu Jagiellońskiego
5.
Szpital Kliniczny im. Heliodora Święcickiego, Katedra Chorób Oczu i Optometrii w Poznaniu
6.
Katedra i Klinika Okulistyki II Wydziału Lekarskiego Warszawskiego Uniwersytetu Medycznego
KLINIKA OCZNA 2021, 123, 2:53–59
Online publish date: 2021/07/14
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Age-related macular degeneration (AMD) is the most common cause of severe visual impairment in older adults in the developed world. Especially neovascular AMD, characterized by rapid progression and a significant reduction in visual acuity, until recently was a therapeutic challenge. The last 15 years have been a period of development of new diagnostic and treatment possibilities. The paper presents recommendations of the Polish Ophthalmological Society for the management of neovascular age-related macular degeneration based on the latest publications.
keywords:
wet AMD, anty-VEGF therapy, recommendations |
|
POLSKI
